189 related articles for article (PubMed ID: 11345039)
1. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
[TBL] [Abstract][Full Text] [Related]
2. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
4. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
5. Chitotriosidase as a marker of macrophage stimulation.
Korolenko TA; Zhanaeva SY; Falameeva OV; Kaledin VI; Filyushina EE; Buzueva II; Paul GA
Bull Exp Biol Med; 2000 Oct; 130(10):948-50. PubMed ID: 11177289
[TBL] [Abstract][Full Text] [Related]
6. Macrophage stimulation and antitumor effect of Ukrain.
Korolenko TA; Svechnikova IG; Filjushina EE; Kaledin VI; Vakulin GM; Usynin IF; Tsyrendordjiev DD
Drugs Exp Clin Res; 1998; 24(5-6):253-60. PubMed ID: 10190084
[TBL] [Abstract][Full Text] [Related]
7. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
Sotomayor EM; Rao K; Lopez DM; Liepins A
Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
[TBL] [Abstract][Full Text] [Related]
9. The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy.
Svechnikova IG; Korolenko TA; Stashko JuF ; Kaledin VI; Nikolin VP; Nowicky JW
Drugs Exp Clin Res; 1998; 24(5-6):261-9. PubMed ID: 10190085
[TBL] [Abstract][Full Text] [Related]
10. [Effect of macrophage stimulators on development of selective depression of liver macrophage in vivo].
Dergunova MA; Korolenko TA; Zhanaeva SIa; Alekseenko TV
Eksp Klin Farmakol; 2010 Nov; 73(11):22-4. PubMed ID: 21254594
[TBL] [Abstract][Full Text] [Related]
11. [Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo].
Kaledin VI; Nikolin VP; Ageeva TA; Timofeeva OA; Filipenko ML; Ronichevskaia GM; Morozkova TS; Popova NA; Baĭmak TIu
Vopr Onkol; 2000; 46(5):588-93. PubMed ID: 11202193
[TBL] [Abstract][Full Text] [Related]
12. Effects of Ukrain on the activities of DNA-nicking enzymes.
Votrin II; Voltchek IV; Kurochkin SN; Kolobkov SL
Drugs Exp Clin Res; 2000; 26(5-6):267-73. PubMed ID: 11345037
[TBL] [Abstract][Full Text] [Related]
13. Ukrain: a novel antitumor drug.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro study of the effects of the new antitumor drug Ukrain and several cytostatic agents on the thiol groups in the tissue of Guerin carcinoma and its resistance to cisplatin variant.
Kulik GI
Drugs Exp Clin Res; 1998; 24(5-6):277-80. PubMed ID: 10190087
[TBL] [Abstract][Full Text] [Related]
15. Studies concerning the effect of Ukrain in vivo and in vitro.
Brüller W
Drugs Exp Clin Res; 1992; 18 Suppl():13-6. PubMed ID: 1305037
[TBL] [Abstract][Full Text] [Related]
16. Ukrain (NSC-631570) influences on bone status: a review.
Jabłoński M
Drugs Exp Clin Res; 2000; 26(5-6):317-20. PubMed ID: 11345045
[TBL] [Abstract][Full Text] [Related]
17. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
[TBL] [Abstract][Full Text] [Related]
18. Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide.
Khalikova TA; Zhanaeva SY; Korolenko TA; Kaledin VI; Kogan G
Cancer Lett; 2005 Jun; 223(1):77-83. PubMed ID: 15890239
[TBL] [Abstract][Full Text] [Related]
19. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
[TBL] [Abstract][Full Text] [Related]
20. Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation.
Boyko VN; Voltchek IV; Petrov AS; Bubnov VP
Drugs Exp Clin Res; 1996; 22(3-5):167-71. PubMed ID: 8899323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
